Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Don’t Expect Abandonment Of US FDA User Fee Programs If They Sunset
Jul 28 2022
•
By
Derrick Gingery
The prospect of a temporary lapse in authorization has stakeholders wondering what happens where the user fees end. • Source: Shutterstock
More from User Fees
More from Pathways & Standards